Effects of the H3 antagonist, thioperamide, on behavioral alterations induced by systemic MK-801 administration in rats

Psychopharmacology

Volumn 205, Issue 4, 2009, Pages 589-597

  Bardgett, Mark E ^a   Points, Megan ^a   Roflow, John ^a   Blankenship, Meredith ^a   Griffith, Molly S ^a  

^a NORTHERN KENTUCKY UNIVERSITY   (United States)

Author keywords

Antipsychotic; Cognition; Locomotor activity; NMDA receptor; Prepulse inhibition; Spatial working memory

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SODIUM CHLORIDE; THIOPERAMIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BEHAVIORAL RESEARCH; DOSE RESPONSE; DRUG DOSE COMPARISON; HYPERACTIVITY; LOCOMOTION; MALE; MONOTHERAPY; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SCHIZOPHRENIA;

ANIMALS; DIZOCILPINE MALEATE; DRUG INTERACTIONS; HISTAMINE H3 ANTAGONISTS; INJECTIONS, SUBCUTANEOUS; MALE; MEMORY; MOTOR ACTIVITY; PIPERIDINES; RATS; RATS, LONG-EVANS; SCHIZOPHRENIA; STARTLE REACTION;

EID: 68149139353     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1566-8     Document Type: Article

References (41)

1. VP Bakshi MA Geyer 1998 Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine J Neurosci 18 8394 8401
2. Bardgett ME (2004) Behavioral models of atypical antipsychotic drug action. In: Csernansky JG, Laurello J (eds) Atypical antipsychotics: from bench to bedside. Marcel Dekker, New York, pp 61-93
3. ME Bardgett PS Jacobs JL Jackson JG Csernansky 1997 Kainic acid lesions enhance locomotor responses to novelty, saline, amphetamine, and MK-801 Behav Brain Res 87 47 55
4. ME Bardgett MS Griffith RF Foltz JA Hopkins CM Massie SM O'Connell 2006 The effects of clozapine on delayed spatial alternation in rats with hippocampal damage Neurobiol Learn Mem 85 86 94
5. ME Bardgett JG Hon NM Lee SM O'Connell KM Baum 2006 Effects of risperidone on locomotor activity and spatial memory in rats with hippocampal damage Neuropharmacology 51 1156 1162
6. ME Bardgett M Points C Ramsey-Faulkner J Topmiller J Roflow T [tmp] McDaniel T Lamontagne MS Griffith 2008 The effects of clonidine on discrete-trial delayed spatial alternation in two rat models of memory loss Neuropsychopharmacology 33 1980 1991
7. P Bernaerts Y Lamberty E Tirelli 2004 Histamine H3 antagonist thioperamide dose-dependently enhances memory consolidation and reverses amnesia induced by dizocilpine or scopolamine in a one-trial inhibitory avoidance task in mice Behav Brain Res 154 211 219
8. P Blandina M Giorgetti L Bartolini M Cecchi H Timmerman R Leurs G Pepeu MG Giovannini 1996 Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats Br J Pharmacol 119 1656 1664
9. C Brabant L Alleva T Grisar E Quertemont B Lakaye H Ohtsu JS Lin P Jatlow MR Picciotto E Tirelli 2009 Effects of the H(3) receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions Psychopharmacology 202 673 687
10. G Brosnan-Watters DF Wozniak A Nardi JW Olney 1996 Acute behavioral effects of MK-801 in the mouse Pharmacol Biochem Behav 53 701 711
11. RE Brown HL Haas 1999 On the mechanism of histaminergic inhibition of glutamate release in the rat dentate gyrus J Physiol 515 777 786
12. KE Browman VA Komater P Curzon LE Rueter AA Hancock MW Decker GB Fox 2004 Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan Behav Brain Res 153 69 76
13. J Clapham GJ Kilpatrick 1992 Histamine H3 receptors modulate the release of [3H]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypes Br J Pharmacol 107 919 923
14. J Clapham GJ Kilpatrick 1994 Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse Eur J Pharmacol 259 107 114
15. H Dai Z Zhang Y Zhu Y Shen W Hu Y Huang J Luo H Timmerman R Leurs Z Chen 2006 Histamine protects against NMDA-induced necrosis in cultured cortical neurons through H receptor/cyclic AMP/protein kinase A and H receptor/GABA release pathways J Neurochem 96 1390 1400
16. H Dai Q Fu Y Shen W Hu Z Zhang H Timmerman R Leurs Z Chen 2007 The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons Eur J Pharmacol 563 117 123
17. NB Farber JW Newcomer JW Olney 1998 The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease Prog Brain Res 116 421 37
18. R Faucard V Armand A Héron V Cochois JC Schwartz JM Arrang 2006 N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain J Neurochem 98 1487 1496
19. JF Flood K Uezu JE Morley 1998 Effect of histamine H2 and H3 receptor modulation in the septum on post-training memory processing Psychopharmacology 140 279 84
20. GB Fox JB Pan RJ Radek AM Lewis RS Bitner TA Esbenshade R Faghih YL Bennani M Williams BB Yao MW Decker AA Hancock 2003 Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization J Pharmacol Exp Ther 305 897 908 (Pubitemid 36617966)
21. GB Fox TA Esbenshade JB Pan RJ Radek KM Krueger BB Yao KE Browman MJ Buckley ME Ballard VA Komater H Miner M Zhang R Faghih LE Rueter RS Bitner KU Drescher J Wetter K Marsh M Lemaire RD Porsolt YL Bennani JP Sullivan MD Cowart MW Decker AA Hancock 2005 Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl) benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist J Pharmacol Exp Ther 313 176 190
22. B Garduño-Torres M Treviño R Gutiérrez JA Arias-Montaño 2007 Pre-synaptic histamine H3 receptors regulate glutamate, but not GABA release in rat thalamus Neuropharmacology 52 527 535
23. AA Hancock 2006 The challenge of drug discovery of a GPCR target: analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists Biochem Pharmacol 71 1103 1113
24. YW Huang WW Hu Z Chen LS Zhang HQ Shen H Timmerman R Leurs K Yanai 2004 Effect of the histamine H3-antagonist clobenpropit on spatial memory deficits induced by MK-801 as evaluated by radial maze in Sprague-Dawley rats Behav Brain Res 151 287 293
25. PS Jacobs BM Taylor ME Bardgett 2000 Maturation of locomotor and Fos responses to NMDA antagonists, PCP and MK-801 Dev Brain Res 122 91 95
26. VA Komater MJ Buckley KE Browman JB Pan AA Hancock MW Decker GB Fox 2005 Effects of histamine H3 receptor antagonists in two models of spatial learning Behav Brain Res 159 295 300
27. S Le JA Gruner JR Mathiasen MJ Marino H Schaffhauser 2008 Correlation between ex vivo receptor occupancy and wake-promoting activity of selective H3 receptor antagonists J Pharmacol Exp Ther 325 902 909
28. X Ligneau J Lin G Vanni-Mercier M Jouvet JL Muir CR Ganellin H Stark S Elz W Schunack J Schwartz 1998 Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist J Pharmacol Exp Ther 287 658 666
29. X Ligneau L Landais D Perrin J Piriou M Uguen E Denis P Robert R Parmentier C Anaclet JS Lin A Burban JM Arrang JC Schwartz 2007 Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649 Biochem Pharmacol 73 1215 1224
30. J Mogensen MH Boyd MD Nielsen RS Kristensen H Malá 2008 Erythropoietin improves spatial delayed alternation in a T-maze in rats subjected to ablation of the prefrontal cortex Brain Res Bull 77 1 7
31. S Morisset UG Sahm E Traiffort J Tardivel-Lacombe JM Arrang JC Schwartz 1999 Atypical neuroleptics enhance histamine turnover in brain via 5-hydroxytryptamine2A receptor blockade J Pharmacol Exp Ther 288 590 596
32. S Morisset C Pilon J Tardivel-Lacombe D Weinstein W Rostene C Betancur P Sokoloff JC Schwartz JM Arrang 2002 Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor J Pharmacol Exp Ther 300 621 628
33. JW Newcomer NB Farber V Jevtovic-Todorovic G Selke AK Melson T Hershey S Craft JW Olney 1999 Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis Neuropsychopharmacology 20 106 118
34. M Orsetti P Ghi G Di Carlo 2001 Histamine H(3)-receptor antagonism improves memory retention and reverses the cognitive deficit induced by scopolamine in a two-trial place recognition task Behav Brain Res 124 235 242
35. C Perez-Garcia L Morales MV Cano I Sancho LF Alguacil 1999 Effects of histamine H3 receptor ligands in experimental models of anxiety and depression Psychopharmacology 142 215 220
36. C Pillot A Heron V Cochois J Tardivel-Lacombe X Ligneau JC Schwartz JM Arrang 2002 A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain Neuroscience 114 173 193
37. BL Roth DJ Sheffler WK Kroeze 2004 Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia Nat Rev Drug Discov 3 353 359
38. JC Schwartz S Morisset A Rouleau X Ligneau F Gbahou J Tardivel-Lacombe H Stark W Schunack CR Ganellin JM Arrang 2003 Therapeutic implications of constitutive activity of receptors: the example of the histamine H3 receptor J Neural Transm Suppl 64 1 16
39. R Takahata B Moghaddam 2003 Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine Neuropsychopharmacology 28 1117 1124
40. DF Wozniak JW Olney L Kettinger 3rd M Price JP Miller 1990 Behavioral effects of MK-801 in the rat Psychopharmacology 101 47 56
41. M Zhang ME Ballard L Pan S Roberts R Faghih M Cowart TA Esbenshade GB Fox MW Decker AA Hancock LE Rueter 2005 Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs Brain Res 1045 142 149